1. Home
  2. > Healthcare
  3. > Health Services Market Trends
Flow Cytometry in Oncology and Immunology Market - A Global Market and Regional: Focus on Offering, Technology, End User, Type, Application, and Country - Analysis and Forecast, 2022-2032

Flow Cytometry in Oncology and Immunology Market - A Global Market and Regional: Focus on Offering, Technology, End User, Type, Application, and Country - Analysis and Forecast, 2022-2032

  • November 2022
  • 286 pages
  • ID: 6364002
  • Format: PDF
  • BIS Research

Summary

Table of Contents

Global Flow Cytometry in Oncology and Immunology Market to Reach $5,287.4 Million by 2032

Global Flow Cytometry in Oncology and Immunology Market Industry Overview

The global flow cytometry in oncology and immunology market was valued at $1,653.2 million in 2021 and is anticipated to reach $5,287.4 million by 2032, witnessing a CAGR of 11.39% during the forecast period 2022-2032. The market is driven by factors such as the increasing burden of cancer, expansion of applications in flow cytometry for research activities, innovation in flow cytometry leading to the use of next-generation flow cytometers, and the increasing use of flow cytometry in the identification and diagnosis of immune-deficiency diseases.

Market Lifecycle Stage

The global flow cytometry in the oncology and immunology market is in the developed phase. The increasing research for flow cytometry for the detection of solid tumors and the leveraging of public-private initiatives to advance R&D in the field of immunology and oncology research are some of the major opportunities in the global flow cytometry in oncology and immunology market.

Impact of COVID-19

COVID-19 had a minimal impact on the global flow cytometry in oncology and immunology market.The initial breakout of the pandemic led to an increase in the use of reagents of flow cytometry in research activities and clinical trials.

However, the manufacturers witnessed a loss in 2020 due to COVID-19 restrictions and preventive actions such as a reduction in supply chain and sales.Also, there was a significant shift observed toward research activities for treating and diagnosing COVID-19, which resulted in a halt in research activities for oncology using flow cytometry.

Besides these minimal impacts, flow cytometry in oncology and immunology is expected to overcome the impact in the forecast period 2022-2032.

Market Segmentation:
Segmentation 1: by Offering
• Products
o Instruments
o Reagents and Consumables
o Software
• Services

The global flow cytometry in oncology and immunology market (by offering) is expected to be dominated by the products segment.

Segmentation 2: by Technology
• Cell-Based Flow Cytometry
• Bead-Based Flow Cytometry

The global flow cytometry in oncology and immunology (by technology) is expected to be dominated by the cell-based flow cytometry segment.

Segmentation 3: by Type
• Immunology
• Oncology

The global flow cytometry in oncology and immunology market (by type) is dominated by the oncology segment.

Segmentation 4: by Application
• Translational Research
• Clinical Research

The global flow cytometry in oncology and immunology market (by application) is dominated by the translational research segment.

Segmentation 5: by End User
• Hospitals, Diagnostic Laboratories, and Reference Laboratories
• Pharmaceutical and Biotechnology Companies
• Academic Research Institutes
• Contract Research Organizations
• Others

The global flow cytometry in oncology and immunology market (by end user) is dominated by the hospitals, diagnostic laboratories, and reference laboratories segment.

Segmentation 6: by Region
• North America - U.S., Canada
• Europe - Germany, France, U.K., Italy, Spain, Netherlands, Rest-of-Europe
• Asia-Pacific - Japan, China, India, Australia, South Korea, Singapore, Rest-of-Asia-Pacific
• Latin America - Brazil, Mexico, Rest-of-Latin America
• Rest-of-the-World

The global flow cytometry in oncology and immunology market (by region) is dominated by the North America segment.

Recent Developments in the Global Flow Cytometry in Oncology and Immunology Market

• In February 2022, Becton, Dickinson and Company acquired Cytognos, S.L. Through this acquisition, the company expanded its flow cytometry portfolio and gained the expertise of ~80 scientists and professionals at Cytognos S.L.
• In September 2022, Becton, Dickinson and Company launched BD Research Cloud, a cloud-based software solution designed to streamline the flow cytometry workflow to enable higher quality experiments with faster time to insight for scientists working across a range of disciplines, including immunology, virology, oncology, and infectious disease monitoring.
• In September 2021, Beckman Coulter, a wholly owned subsidiary of Danaher Corporation, launched its new CytoFLEX flow cytometry platform, which is expected to open new avenues for cancer researchers with respect to single-cell analysis. This new system launched by the company offers powerful analytical performance in a benchtop instrument, which offers high sensitivity.
• In February 2021, Thermo Fisher Scientific Inc. acquired the cell sorting technology assets of Propel Labs, which is expected to broaden Thermo Fisher’s flow cytometry and cell analysis portfolio.
• In December 2020, Thermo Fisher Scientific Inc. acquired Phitonex, Inc., a pioneer in the field of spectral dye platforms for high-resolution biological applications, including oncology and immunology. With the acquisition of the company, Thermo Fisher Scientific Inc. is expected to offer greater flow cytometry capabilities to meet evolving customer demands for cell and protein analysis research.
• In January 2020, Luminex Corporation acquired Merck’s flow cytometry business portfolio for $75 million, further enabling the company to effectively enhance its existing offerings related to flow-based detection instruments. The company’s newly acquired FCM portfolio includes Guava and Amnis product portfolios.

Demand – Drivers and Limitations

Following are the drivers for the global flow cytometry in oncology and immunology market:
• Increasing Burden of Cancer is One of the Major Propelling Factors for the Innovation of Novel Technologies in Flow Cytometry
• Expansion of Applications in Flow Cytometry for Research Activities Propels its Demand in the Market
• Innovation in Flow Cytometry Leading to Use of Next-Generation Flow Cytometers
• Increasing Use of Flow Cytometry in Identification and Diagnosis of Immune-Deficiency Diseases

The market is expected to face some limitations as well due to the following challenges:
• High Cost of the Products of the Flow Cytometry Equipment Restraining the Adoption of the Devices in Emerging Economies
• False Negative and Positive Antibody Responses Can Hinder the Adoption of Flow Cytometry

How can this report add value to an organization?

Offerings: The offerings segment helps the reader understand the different types of flow cytometry offerings available in the market. Moreover, the study provides the reader with a detailed understanding of products that fall under the two main segments, i.e., products and services.

Growth/Marketing Strategy: The global flow cytometry in oncology and immunology market has witnessed major development by key players operating in the market, such as product launches, business expansions, partnerships, collaborations, mergers and acquisitions, funding activities, and regulatory and legal approvals.The favored strategy for the companies has been new product offerings to strengthen their position in the market.

For instance, in June 2022, Becton, Dickinson and Company launched its new cell sorting technology at the International Society for Advancement of Cytometry (ISAC). Using this technology can help in sorting cells at a very fast speed during flow cytometry.

Competitive Strategy: The key players in the global flow cytometry in oncology and immunology market analyzed and profiled in the study involve established and emerging players that offer different products for flow cytometry.Moreover, a detailed competitive benchmarking of the players operating in the global flow cytometry in oncology and immunology market has been done to help the reader understand the ways in which players stack against each other, presenting a clear market landscape.

Moreover, comprehensive competitive strategies such as partnerships, agreements, collaborations, mergers, and acquisitions will help the reader understand the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some of the players in this market are:
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Cell Signaling Technology, Inc.
• Cytek Biosciences, Inc.
• Danaher Corporation
• DiaSorin S.p.A (Luminex Corporation)
• Enzi Biochem Inc.
• Laboratory Corporation of America Holdings
• Merck KGaA
• Miltenyi Biotec
• NeoGenomics Laboratories, Inc.
• OPKO Health, Inc.
• Sony Group Corporation
• Thermo Fisher Scientific Inc

Countries Covered
• North America
• U.S.
• Canada
• Europe
• Germany
• Italy
• France
• U.K.
• Spain
• Netherlands
• Rest-of-Europe
• Asia-Pacific
• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest-of-Asia-Pacific
• Latin America
• Brazil
• Mexico
• Rest-of-Latin America
• Rest-of-the-World

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Digital Health in Immunology Market Size, Share and Trends Analysis by Region, Product, Technology (Telemedicine, mHealth, Digital Therapeutics, Others), Therapy Area (Dermatology, Rheumatology, Gastroenterology) and Segment Forecast, 2022-2027

  • $ 3950
  • November 2022
  • 103 pages

Digital Health in Immunology Market Size, Share and Trends Analysis by Region, Product, Technology (Telemedicine, mHealth, Digital Therapeutics, Others), Therapy Area (Dermatology, Rheumatology, Gastroenterology) ...

  • World
  • Europe
  • Digital Health
  • Immunology
  • Industry analysis
  • Medical Technology Density
  • Health Provider Density

ref:plp2022

Reportlinker.com © Copyright 2023. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on